| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.48B | +8.2% |
| R&D Expense | $26.0M | -3.7% |
| SG&A Expense | $977.0M | +0.4% |
| Operating Income | $657.0M | +22.8% |
| Interest Expense | $105.0M | +10.5% |
| Pre-tax Income | $777.0M | +20.8% |
| Income Tax | $172.0M | +84.9% |
| Net Income | $605.0M | +10.0% |
| EPS (Basic) | $15.39 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $339.0M | +59.9% |
| Current Assets | $3.45B | +6.9% |
| Total Assets | $12.75B | +5.0% |
| Current Liabilities | $3.04B | +1.8% |
| Long-term Debt | $2.70B | +0.0% |
| Total Liabilities | $7.68B | +2.7% |
| Stockholders' Equity | $5.07B | +8.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.20B | +204.3% |
| Capital Expenditures | $402.0M | +9.5% |
| Investing Cash Flow | -$521.0M | -49.7% |
| Financing Cash Flow | -$732.0M | -305.6% |
| Free Cash Flow | $794.0M | +2953.8% |
| +10.2% |
| EPS (Diluted) | $15.39 | +10.2% |